chrisvoncsefalvay/vaers-outcomes huggingface dataset:
arm sorness; Redness at injection site; Fever of 100; Body aches; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (arm soreness), VACCINATION SITE JOINT PAIN (Redness at injection site), PYREXIA (Fever of 100), PAIN IN EXTREMITY (Body aches) and CHILLS (Chills) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included Blood pressure pills, METOPROLOL, CHOLESTEROL, AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3), TADALAFIL (CIALIS) and low dose aspirin for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced PYREXIA (Fever of 100), PAIN IN EXTREMITY (Body aches), CHILLS (Chills) and FATIGUE (Fatigue). On 24-Apr-2021, the patient experienced VACCINATION SITE JOINT PAIN (Redness at injection site). On an unknown date, the patient experienced LIMB DISCOMFORT (arm soreness). On 23-Apr-2021, PYREXIA (Fever of 100), PAIN IN EXTREMITY (Body aches) and CHILLS (Chills) had resolved. On 24-Apr-2021, FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE JOINT PAIN (Redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
unable to lift up rt leg, could not walk up stairs, pain in groin; took one week of gradual recovery of condition a/complete use of leg was possible;
Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 17-NOV-2015, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 03-JAN-2017, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
Had shot on 10-21-16 on 10-25-16 I could not open my mouth far my sides of my ears hurt. On the 10-26-16 I had trouble lifting my feet over a very slight raise in our floor. I had got a walker that night, but I could not get out of my chair so the ambulance came on 10-27-16 to the hosp. I went.
Flu-like symptoms for 2 days, then again one week later including increased heart rate, sweating, shakes, lightheadedness, decreased appetite, significant weight loss (15 lbs).
Information has been received from a physician concerning a school age patient who was vaccinated with a dose of varicella virus vaccine live.  "last week", in February 2006, the patient experienced chickenpox.  Unspecified medical attention was sought.  No product quality complaint was involved.  No other information was provided.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/12/2006. Information has been received from a physician concerning a 6 year old patient who in 1997 or 2000, was vaccinated with a dose of VARIVAX (MERCK). "Last week", in February 2006, the patient experienced chickenpox. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that the patient had a small amount of vesicles. It was reported that the vesicles had cleared completely. No other information was provided. Additional information is not expected.
No additional AE reported.; A medical assistant called to report an expired  VAQTA was administered to a patient.; This spontaneous report was received from a medical assistant and refers to a 52-year-old male patient. The patient's pertinent medical history, concomitant medication, previous drug reactions, and allergies were not reported.      On 21-APR-2021, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) prefilled syringe (lot number T014590, which has been verified to be valid, the expiration date was reported and validated as 15-APR-2021) 1 milliliter (ml) once, as prophylaxis (expired product administered) (route of administration and anatomical site of vaccination were not provided). The suspect vaccine had not had any prior temperature excursions. Supported disclaimer was provided. No additional adverse event was reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T014590; expirationdate: 15-APR-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
A few days after the inoculation a red circle about 1 1/2 cm appeared at the site of the shot.
Sore throat, neck pain, low grade fever, diarrhea (loose stools) x2 days. Pt instructed to go the Emergency Dept.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. A 75 year-old male patient received bnt162b2 (BNT162B2), administration date 25Feb2021 (Batch/Lot number: unknown) at the age of 75 years as dose 1,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NERVE COMPRESSION (non-serious), outcome "unknown", described as "pinched nerve". Additional Information: The patient  went to the doctor 2 days ago for a pinched nerve in his back and was given a prescription for prednisone. The patient told the doctor he had just had the vaccine a few days before. Caller sat on hold with the CDC hotline for two hours and was disconnected. The patient had read online no to take anti-inflammatory drugs, alcohol, or pain medications for 2 weeks after getting the vaccine because it could reduce the efficacy of the vaccine. Should he not take this prednisone?  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt vaccinated with DTP developed low fever x 24 hrs, vomitted x 2, became excessively sleepy after shot, lasted x 72 hrs.
High Fever -102 Chills & Body Aches Neck Pain  Headache Vomiting Nausea
2 days after receiving immunizations, patient developed diffuse red urticarial-type rash on face, neck, extremities. Hands/ feet also red/swollen, but no obvious pain.
Reporter states doctor injected an office worker w/Hep B vax (recomb) 40mcg instead of 10mcg; @ time of the report there was no adverse rxn; No further details were provided;
This spontaneous report was received from nurse practitioner referring to a patient of unknown age and gender. No pertinent medical history and concurrent conditions reported. on 21-JUL-2014 patient received improperly stored MMR II [lot # J010993/ exp. date 09/06/2015] exposed to 9.7 degree for 6 hours 20 minutes, subcutaneously (dose not reported). No other concomitant therapies reported. No adverse effects reported. The outcome of the events was unknown. No PQC reported. The case has been linked with the cases 1407USA012136, 1407USA014425, 1407USA014427, 1407USA014428, 1407USA014429, 1407USA014430, 1408USA000005, 1408USA000006, 1408USA000009, 1408USA000012, 1408USA000015, 1408USA000832, 1408USA000838, 1408USA000843, 1408USA000848 and 1408USA000853. Additional information has been requested.
client c/o SOB/ DIZZINESS about 1.5 hours after vaccine administration. On arrival back to Nurses Station client A&O x 4, but requested 911 be called due to previous stroke history and concern over symptoms. 911 called immediately. Client symptoms resolved after ambulance arrived @ 12:00 client. Checked BP= 118/70 / RR=18/P=88/7=97.4.
No adverse effects; A patient was administered PROQUAD and VARIVAX on the same day; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent condition, drug reactions or allergies and concomitant medication were not reported.      On 1-NOV-2019, The nurse identified the patient was vaccinated on unspecified date with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (lot # S008569 has been verified to be a valid number; expiration date 16-SEP-2020, and upon internal validation established as the same date); and varicella virus vaccine live (oka/merck)(VARIVAX) (lot number S011951 has been verified to be a valid number; expiration date 16-APR-2021, and upon internal validation established as the same date), both vaccines subcutaneously for prophylaxis (strength, dose, anatomical site of vaccination were not reported) on the same day  (overdose).  Also, it was reported no adverse effects.
Redness in the face/Redness in the neck; throat itchy; arm itchy; She feels like little needles that prick; Patient is having a rash in the face/Patient is having a rash in the neck; Allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness in the face/Redness in the neck), THROAT IRRITATION (throat itchy), PRURITUS (arm itchy), PAIN (She feels like little needles that prick) and RASH (Patient is having a rash in the face/Patient is having a rash in the neck) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939909) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hyperthyroidism. Concomitant products included LEVOTHYROXINE for Hyperthyroidism.    On 19-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Nov-2021, the patient experienced ERYTHEMA (Redness in the face/Redness in the neck), THROAT IRRITATION (throat itchy), PRURITUS (arm itchy), PAIN (She feels like little needles that prick), RASH (Patient is having a rash in the face/Patient is having a rash in the neck) and HYPERSENSITIVITY (Allergic reaction). At the time of the report, ERYTHEMA (Redness in the face/Redness in the neck), THROAT IRRITATION (throat itchy), PRURITUS (arm itchy), PAIN (She feels like little needles that prick), RASH (Patient is having a rash in the face/Patient is having a rash in the neck) and HYPERSENSITIVITY (Allergic reaction) outcome was unknown.            No concomitant medications were reported.   No treatment information was provided.
Patient hospitalized for vaginal delivery within 6 weeks of receiving COVID vaccination.  Patient had spontaneous rupture of membranes at 39 weeks. There was meconium stained fluid at delivery. No information available for status of baby.
recieved MMR Shot on 9/27/05 and 6 days later she lost all her hair. Has the dx. aleopecia totalis. has had no hair growth since .
-Swelling and redness in the arm still remains to date -Patient did had numbness in her fingers but it has resolved -Patient also had low grade fever after shot but it has resolved since then
p/leaving clinic pt became faint, reported blurred vision & fainted (w/LOC) in store parking lot was quickly roused & transported to ER by mom;vomited profusely in ER & given compazine along w/IV rehydration;left ER w/mom & c/o arthralgia;
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age. The patients were vaccinated with a late second dose of GARDASIL (Lot# not reported) on an unspecified date. No symptoms were reported. The physician also reported that there were an unspecified number of patients who have received other unspecified vaccine doses late but he was unable to provide the names of the other vaccines. No symptoms were reported. The physician stated that patients received vaccine doses late usually because they were in school or because they lived far away so it was difficult for them to return for their follow up doses. Additional information is not expected.
I received the vaccine with no issues, within a few hours i experienced a minor headache. I went to class and woke up the next morning cold. I couldn?t get out of bed, I was weak, Nauseous, head was pounding. I was brought 800mg of ibroprofen and a thermometer. I temperature was a 103.7. I monitored my temperature all day long. My fever broke around noon, still sick. Around 3:00pm it returned at a 100.6. I went to bed for the day with the fever after taking more ibroprofen later that day and woke the next morning with a headache but other than that without symptoms. On today (May 4th) I still have a headache, but without symptom.
Within 4 hours of injection left hand began to turn light red over top of hand, continued getting redder for 10 days, day 10 evening left hand started to swell, became painful and warm to touch.  Day 11, 12, and 13 left hand gets darker red, more swelling, extremely painful, can not touch anything to skin, and right hand begins to get light red.  Day 14 seen at primary doctor, prednisone prescribed, skin now oozing clear fluid.  2nd prescription of Prednisone given after initial 5 days as swelling has subsided about half.  After 10 days on Prednisone swelling is pretty much gone, pain has lessened but hard red skin has started peeling away exposing new pink skin and continues to do so   Right hand has not started peeling yet but will do to the fact that he skin is hard and red but smaller area.  Office visit with Wound Care on April 1 they gave me Venelex salve for the hand wounds.  Recheck on April 5th with  Family Practice advised no current infection showing on hands,  instructed to keep clean, use Venelex and call if conditions change.  April 6 saw Vascular doctorand we have delayed foot surgery due to condition of left hand.  April 6th 6:00 left entire top of foot and sides of foot up to and including approximately 4 inches of left ankle are now red and swollen with apperance just like being of hand issues.  Appointment with  Wound Care tomorrow will aask them to assertain and I will also contact  Family Practice .  Pain is starting in left foot from swelling is what I assume.  I have taken several photos of left and right hands during the past timeframe and have also now taken a photo of the left foot to document.
shaking vigorously; Fever; Her daughter fell one time and hit her head.; Passing out; Throwing up; This is a spontaneous report from a contactable consumer or other non hcp (Parent). A 13-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: FC3183) via an unspecified route of administration, administered in Arm Left on 23Aug2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: not reported) via an unspecified route of administration, as dose 1, single for covid-19 immunisation.The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks prior to the COVID vaccine. Adverse events following prior vaccinations was none. Reporter confirms her daughter received her second shot on 23Aug2021.The reporter states the throwing up and passing out is getting worse it seems. She thought it was going to get better. The caller thought it was just side effects that would go away, work itself out, but it's not. Her daughter is missing a lot of school. Her daughter is in bed right now. The Reporter states that the first time her daughter's symptoms began, her daughter was shaking vigorously. Her daughter couldn't stop. The Reporter asked her daughter if she was cold, and her daughter responded that she wasn't, and that she didn't know what was happening and asked the reporter to help her. The reporter didn't know what was going on. The caller clarifies this happened at 02:30 in the morning, (early the next morning after receiving the shot). The Reporter states she was scared and then her daughter got a fever. The Reporter called the ER and explained something was wrong with her daughter (it was the same night, clarified as early the next morning after receiving the second shot). The reporter was by herself with her daughter and it was scary her daughter blacked out. When she called the ER, the ER told her to not come in, it was just side effects of the shot. She took her daughter to the doctor the next morning and they have been running test on her ever since. The doctors have done blood work, an EKG, some other things. They plan to do a brain MRI. The reporter doesn't know what happened, but it started right after the shot. Ever since then, it's happened 3 or 4 times a week. Her daughter fell one time and hit her head. One time it was in the tub. Other times its been in her room. The outcome of the events syncope and vomiting was not recovered and for all other events it was unknown.
Information has been received from a legal firm regarding a case in litigation concerning a male child who was exposed to vaccines containing thimerosal beginning in or about 1998 up through and including 2001 and every time he received a multi-dose vaccine. It is alleged that as a result of the vaccines containing thimerosal, the pt sustained severe and permanent personal injuries, including being dx'd with autism and other neurological disorders. It is also alleged that the pt sustained further neurological insult from other vaccines, including MMRII which does not contain thimerosal but caused further neurological insult and exacerbated the neurological disorders from the prior thimerosal exposure. Upon internal review, autism, neurological disorders, exacerbation of neurological disorders and permanent personal injuries were considered to be "Other Important Medical Events". Additional information has been requested.
PATIENT REPORTS RESPIRATORY DISTRESS, LOCAL REDNESS, BLISTERS, DIFFICULTY WALKING, MUSCULAR PAIN, TACHYCARDIA, ITCHING EYES, BODY, CHEST PAIN, AXULARY LYMPH NODES INFLAMATION, NOSE AND THROAT HEMORRAGE, FEVER, HEADCAHE,
Patient experienced increased tachypnea, desaturated, bradycardia, and lethargy right after receiving both Haemophilus and Pediarix vaccines.
Very swollen, red, warm to touch at injection site. Very itchy as well. Now 21 days later still red and skin looks as if very dry and flaky
irritable x72hr, fever x24hr, crying inconsolable for 60min plus periods intermittently;
21yo F patient with no PMH, here to receive the Pfizer COVID vaccine booster. Immediately after receiving the vaccine she felt her "head was tense". Patient is associating the event to the fact that she was very anxious and scare about the vaccine. With the primary 2 doses she had lightheadedness that self-resolved within minutes. Denied any other symptom. Patient was evaluated by on-site EMS and MD. On PE AAO x 3; Initial VS: HR 77, RR 18, SpO2 100%, BP 110/60. Heart with RRR, lungs clear bilaterally. Patient was offered water and juice. After 15min observation patient felt better, repeated set of VS within normal limits. Patient was discharged with complete resolution of symptoms.
This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 64-year-old female patient who received SHINGRIX (batch number EK279, expiry date 31st March 2020). Concomitant products included Multivitamin. On 20th March 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 21st March 2018, 1 days after receiving SHINGRIX, the patient experienced injection site pain, fatigue, general body pain, fever, shivering, influenza-like symptoms and inability to work. On an unknown date, the outcome of the injection site pain, fatigue, general body pain, fever, shivering, influenza-like symptoms and inability to work were recovering/resolving. The reporter considered the injection site pain, fatigue, general body pain, fever and shivering to be related to SHINGRIX. It was unknown if the reporter considered the influenza-like symptoms and inability to work to be related to SHINGRIX. Additional information was reported as follows: Concomitant products included OTC multivitamin. The patient received SHINGRIX in left deltoid. The lot number and expiration date were provided from box as the actual product vial was already discarded. The symptoms described as flu-like symptoms began the next morning of the day after the vaccination was administered. The patient felt she could not do her job for two days, so she missed 21st March 2018 and 22nd March 2018 work days. She had not had to take any medicine for any of the symptoms. At the time of reporting the patient was back at work and told the nurse she was feeling better but not completely herself. The arm soreness was at the left deltoid muscle area at the injection site. The nurse indicated she needed to check the patient, so no further information was provided due to time constraints. She granted permission to be contacted with further related questions.
FEVER; BURNING IN EYES; COUGH; HEADACHE; CHILLS; INJECTION SITE PAIN; TIREDNESS; NAUSEA; This spontaneous report received from a patient concerned a 37 year old female. The patient's height, and weight were not reported. The patient's past medical history included seasonal allergies, and non-alcoholic, and concurrent conditions included cigarette smoker, and other pre-existing medical conditions included  patient had no drug abuse or illicit drug use. Cigarette smoking: half-a-pack a day. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number:1808980) dose was not reported, administered on 07-APR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced injection site pain. On 07-APR-2021, the subject experienced tiredness. On 07-APR-2021, the subject experienced nausea. On 24-APR-2021, the subject experienced headache. On 25-APR-2021, the subject experienced cough. On 26-APR-2021, the subject experienced fever. On 26-APR-2021, the subject experienced burning in eyes. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 100.0 F. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, injection site pain, tiredness, and nausea on 08-APR-2021, had not recovered from fever, headache, and cough, and the outcome of burning in eyes was not reported. This report was non-serious.
Pt. states that after receiving the 2nd dose of Moderna 09/16/2021, started experiencing symptoms 10/07/2021 of red spots on the left side of the chest (breast area) up the collarbone, throughout the backside of the shoulder blade (itchiness associated).  Fever, fatigue, muscle spasms (left arm), and swollen lymphnoids (left underarm).  No noted Primary visit/communications.